These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12218510)

  • 1. The effects of selective dopamine agonists on a passive avoidance learning task in the day-old chick.
    Hale MW; Crowe SF
    Behav Pharmacol; 2002 Jul; 13(4):295-301. PubMed ID: 12218510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the dopamine D3 receptor agonist, R(+)-7-hydroxy-N,N-di-n-propyl-2-aminotetralin, on memory processes in mice.
    Ukai M; Tanaka T; Kameyama T
    Eur J Pharmacol; 1997 Apr; 324(2-3):147-51. PubMed ID: 9145765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitatory effect of the dopamine D4 receptor agonist PD168,077 on memory consolidation of an inhibitory avoidance learned response in C57BL/6J mice.
    Bernaerts P; Tirelli E
    Behav Brain Res; 2003 Jun; 142(1-2):41-52. PubMed ID: 12798264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
    Koshikawa N; Kitamura M; Kobayashi M; Cools AR
    Eur J Pharmacol; 1996 Jul; 308(3):235-41. PubMed ID: 8858293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus effects of putative D3 dopamine receptor agonists in rats.
    Katz JL; Alling KL
    Behav Pharmacol; 2000 Sep; 11(6):483-93. PubMed ID: 11103914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective attenuation of the antinociceptive effects of mu opioids by the putative dopamine D3 agonist 7-OH-DPAT.
    Cook CD; Rodefer JS; Picker MJ
    Psychopharmacology (Berl); 1999 Jun; 144(3):239-47. PubMed ID: 10435390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dopamine D3 receptor agonist, 7-OH-DPAT, causes vomiting in the dog.
    Yoshida N; Yoshikawa T; Hosoki K
    Life Sci; 1995; 57(21):PL347-50. PubMed ID: 7475938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of D3 versus D2 receptor modulation of the discriminative stimulus effects of (+)-7-OH-DPAT in rats.
    Baker LE; Hood CA; Heidema AM
    Behav Pharmacol; 1999 Dec; 10(8):717-22. PubMed ID: 10780286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew).
    Darmani NA; Zhao W; Ahmad B
    J Neural Transm (Vienna); 1999; 106(11-12):1045-61. PubMed ID: 10651102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation.
    Collo G; Zanetti S; Missale C; Spano P
    Eur J Neurosci; 2008 Oct; 28(7):1231-40. PubMed ID: 18973551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The locomotor effects of a putative dopamine D3 receptor agonist in developing rats.
    Frantz K; Babcock D; Van Hartesveldt C
    Eur J Pharmacol; 1996 Apr; 302(1-3):1-6. PubMed ID: 8790984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facilitation and disruption of memory for the passive avoidance task in the day-old chick using dopamine D1 receptor compounds.
    Hale MW; Crowe SF
    Behav Pharmacol; 2003 Nov; 14(7):525-32. PubMed ID: 14557720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7-Hydroxy-N,N'-di-n-propyl-2-aminotetraline, a preferential dopamine D3 agonist, induces c-fos mRNA expression in the rat cerebellum.
    Ishibashi T; Wakabayashi J; Ohno Y
    Jpn J Pharmacol; 2002 Jul; 89(3):309-15. PubMed ID: 12184738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; jaw movements.
    Koshikawa N; Miwa Y; Adachi K; Kobayashi M; Cools AR
    Eur J Pharmacol; 1996 Jul; 308(3):227-34. PubMed ID: 8858292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biphasic inhibition of stimulated endogenous dopamine release by 7-OH-DPAT in slices of rat nucleus accumbens.
    Patel J; Trout SJ; Palij P; Whelpton R; Kruk ZL
    Br J Pharmacol; 1995 Jun; 115(3):421-6. PubMed ID: 7582452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of putative dopamine D3 receptor agonists, 7-OH-DPAT, and quinpirole, on yawning, stereotypy, and body temperature in rats.
    Kurashima M; Yamada K; Nagashima M; Shirakawa K; Furukawa T
    Pharmacol Biochem Behav; 1995 Nov; 52(3):503-8. PubMed ID: 8545466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D2 and D1 dopaminergic activity of 7-OH-DPAT.
    Sethy VH; Ellerbrock BR; Fici GJ; Wu H
    Brain Res; 1996 Sep; 733(1):41-5. PubMed ID: 8891246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of [3H]R(+)-7-OH-DPAT binding in the rat caudate-putamen.
    Hillefors M; von Euler G
    Neurochem Int; 2001 Jan; 38(1):31-42. PubMed ID: 10913686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral interactions produced by co-administration of 7-OH-DPAT with cocaine or apomorphine in the rat.
    Khroyan TV; Fuchs RA; Beck AM; Groff RS; Neisewander JL
    Psychopharmacology (Berl); 1999 Mar; 142(4):383-92. PubMed ID: 10229063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.